The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Novel Methods To Diagnose Clinical Egg Allergy And Predict Prognostic Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Australia has the highest rate of food allergy in the world. Despite ongoing research into the area, there is currently no cure, with patient avoidance the most effective way to prevent food reactions. A food challenge is the gold standard for food allergy diagnosis. Although definitive, it is associated with a risk of anaphylaxis. My research aims to identify the biological differences between having food allergy and not having food allergy to develop novel diagnostic methods.
The Role Of IL21 In Integrating Proliferation, Migration And Differentiation Following B Cell Activation.
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Immunity is essential to health and requires the production of antibodies. The best antibodies are made by B-cells coming from specialised structures, called germinal centres (GC). To understand why sometimes immunity is excellent - childhood vaccines - and other times not - HIV infection, aged people - we need to understand what happens inside GC. Our prediction is that by understanding GC B cell behaviour, we will resolve good from poor immune responses and thereby develop improvements.
The Development Of Novel Antibody Constructs And Peptides To Prevent Pathogenic Modulation Of The Immune Response
Funder
National Health and Medical Research Council
Funding Amount
$335,825.00
Summary
The current lack of effective vaccines, as well as the emergence of drug resistance, underpins the need for the development of novel therapeutics to treat bacterial infections and malaria. In this project, I will be using computer-based molecular modelling techniques to design novel antimicrobial treatments.